Where is Molecular Partners headquartered?

Molecular Partners is located in Schlieren, zurich.

Who invested in Molecular Partners?

Molecular Partners has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Molecular Partners raised to date?

Molecular Partners has raised ____.

When was the last funding round for Molecular Partners?

Molecular Partners closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

molecularpartners.com

Molecular Partners

Molecular Partners is a Switzerland-based biotechnology company that develops and commercializes custom-built protein therapeutics for the treatment of cancer.

Business Model:

Revenue: $10.7M

Employees: 51-200

Geographic Data

Address: Wagistrasse 14

City: Schlieren

State: zurich

Zip: 8952

Country: CH

Financial Info

Stage:

post ipo equity

Raised Last:

$44M

Raised Total:

$189M

Social

Twitter

Crunchbase

Metrics

1,711,612Website Global Rank

13,605Website Monthly Traffic

Twitter Followers

Description

Molecular Partners is a Switzerland-based biotechnology company that develops and commercializes custom-built protein therapeutics for the treatment of cancer.

Contact Phone:

Contact Email:

IPO Details

Molecular Partners went public on 6/16/2021 on the SIX Swiss Exchange

Listed Exchange:
SIX Swiss Exchange

IPO Date:
6/16/2021

IPO Valuation:
$683M

Ticker Symbol:
MOLN

IPO Price:
$21.25/share

Amount Raised:
$64M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
7/2020	Private Placement		$85.1M	Suvretta Capital Management, LLC Camber Capital Management LP BVF Partners L.P. Federated Hermes Kaufmann Funds Monashee Investment Management LLC
7/2020	Post-IPO Equity		$0	Federated Kaufmann Fund BVF Partners Camber Capital Corp Suvretta Capital Management Federated Kaufmann Fund BVF Partners Camber Capital Corp Suvretta Capital Management
8/2007	Series A		$15.6M	Index Ventures BB Biotech Ventures Johnson & Johnson Development Corporation Endeavour Capital
8/2007	Series A	4	$15.6M	Index Ventures Johnson &a; Johnson Development Corporation Endeavour Vision BB Biotech Ventures Index Ventures
12/2009	Series B	5	$44.2M	Endeavour Vision Johnson &a; Johnson Development Corporation Index Ventures BB Biotech Ventures Essex Woodlands Healthcare Partners Essex Woodlands Healthcare Partners Endeavour Vision Johnson &a; Johnson Development Corporation Index Ventures BB Biotech Ventures Essex Woodlands Healthcare Partners Essex Woodlands Healthcare Partners
11/2014	IPO		$102.2M
10/2020	Post-IPO Equity	1	$43.9M	Novartis Novartis Novartis Novartis
11/2014	IPO		$100M
7/2020	Post-IPO Equity	4	$85.1M	Federated Kaufmann Fund BVF Partners Camber Capital Corp Suvretta Capital Management Federated Kaufmann Fund BVF Partners Camber Capital Corp Suvretta Capital Management

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details